LYTIR

Insider · SEC Form 4 · Chief Financial Officer

Christopher Ryan Sullivan

Filed with the SEC as Sullivan Christopher Ryan; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.8M of AVTX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.8M in total.Aug: Insider sales $1.5MSep: Insider sales $382KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. AVTXSold: Avalo Therapeutics, Inc. Sep 16, 2026 12,394 shares filed Sep 18, 2026 39,900 shares held directly after, as filed 10b5-1 plan filing $202K
  2. AVTXSold: Avalo Therapeutics, Inc. Sep 10, 2026 10,185 shares filed Sep 11, 2026 39,900 shares held directly after, as filed 10b5-1 plan filing $179K
  3. AVTXSold: Avalo Therapeutics, Inc. Aug 18, 2026 31,031 shares filed Aug 19, 2026 39,900 shares held directly after, as filed 10b5-1 plan filing $622K
  4. AVTXSold: Avalo Therapeutics, Inc. Aug 17, 2026 41,694 shares filed Aug 19, 2026 2 transactions 10b5-1 plan filing $828K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • AVTX: option exercise or conversion (code M), 5 entries, Aug 17 to Sep 16, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.